GORDON CARL L

Director at BIOCRYST PHARMACEUTICALS INC · on record since May 18, 2006
Director at ArriVent BioPharma, Inc. · on record since Jan 31, 2024
10% owner at ArriVent BioPharma, Inc. · on record since Jan 31, 2024
Director at MBX Biosciences, Inc. · on record since Sep 17, 2024
10% owner at MBX Biosciences, Inc. · on record since Sep 17, 2024
Director at Lomond Therapeutics Holdings, Inc. · on record since Nov 5, 2024
Director at ACADIA PHARMACEUTICALS INC · on record since May 26, 2004
Director at AMARIN CORP PLC\UK · on record since Dec 30, 2010
Director at COMPLETE GENOMICS INC · on record since Nov 10, 2010
Director at Pacira BioSciences, Inc. · on record since Feb 10, 2011
Director at Theseus Pharmaceuticals, Inc. · on record since Oct 14, 2021
10% owner at Theseus Pharmaceuticals, Inc. · on record since Oct 14, 2021
Director at Scribe Therapeutics, Inc. · on record since Jul 23, 2026
Director at ACCELERON PHARMA INC · on record since Sep 18, 2013
Director at Cartesian Therapeutics, Inc. · on record since Jun 29, 2016
10% owner at Cartesian Therapeutics, Inc. · on record since Jun 29, 2016
Director at Intellia Therapeutics, Inc. · on record since May 11, 2016
10% owner at Intellia Therapeutics, Inc. · on record since May 9, 2016
Director at BlossomHill Therapeutics, Inc. · on record since Aug 6, 2026
10% owner at · on record since Sep 23, 2026
Director at · on record since Nov 20, 2017
10% owner at · on record since Nov 20, 2017
Director at · on record since Jan 30, 2018
10% owner at · on record since Jan 30, 2018
Director at · on record since Sep 24, 2026
10% owner at · on record since Sep 24, 2026
Director at · on record since Feb 11, 2019
10% owner at · on record since Feb 11, 2019
Director at · on record since Jun 26, 2019
10% owner at · on record since Jun 26, 2019
Director at · on record since Apr 24, 2019
Director at · on record since Sep 12, 2019
10% owner at · on record since Sep 12, 2019
Director at · on record since Apr 28, 2020
10% owner at · on record since Apr 28, 2020
Director at · on record since Apr 13, 2020
Director at · on record since Dec 9, 2020
10% owner at · on record since Dec 9, 2020
Director at · on record since Feb 26, 2021
10% owner at · on record since Feb 26, 2021
10% owner at · on record since Feb 18, 2021
Director at · on record since Feb 10, 2021
10% owner at · on record since Feb 10, 2021
10% owner at · on record since Mar 17, 2023
Director at · on record since Sep 17, 2020
Director at · on record since Jun 23, 2020
10% owner at · on record since Jun 23, 2020
Director at · on record since Sep 18, 2026

Insider trading activity of GORDON CARL L

Transactions on record: 434; since Mar 10, 2004

Open-market buys: 89; $241.9M

Open-market sells: 75; $148.8M

Companies traded: 28; last filing Sep 30, 2026

Figures computed from official regulatory filings — .

Companies where GORDON CARL L has traded

19 tx · $16.2M · Sep 30, 2026
10 tx · $20M · Sep 23, 2026
6 tx · $10M · Aug 12, 2026
4 tx · $15M · Jul 29, 2026
16 tx · $33.6M · Jan 5, 2026
15 tx · $20.8M · Dec 18, 2025
12 tx · $14M · Feb 19, 2025
13 tx · $10M · Nov 5, 2024
36 tx · $19.1M · Aug 23, 2024
26 tx · $18.6M · Jul 17, 2024
3 tx · $2.2M · May 20, 2024
45 tx · $24.7M · Apr 5, 2024
24 tx · $14.5M · Feb 14, 2024
10 tx · $8M · Jan 31, 2024

Track record of GORDON CARL L

Statistical track record

Free account

Open-market buys: 92

Last buy: Sep 28, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of GORDON CARL L

Co-insiders of GORDON CARL L

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-513,067	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-10,690,530	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	513,067	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Buy	588,235	17.00 USD	$10M	conv 59Cluster	SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	769,601	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	1,333,975	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-564,187	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-7,127,019	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-2,000,962	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	564,187	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	10,690,530	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Buy	300,249	17.00 USD	$5.1M	conv 39Cluster	SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	7,127,019	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	2,000,962	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-1,333,975	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-256,448	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Buy	61,516	17.00 USD	$1M	conv 37Cluster	SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	256,448	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-769,601	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Electra Therapeutics, Inc.Listing unverified	Sep 23, 2026	OtherD (derivative)	-1,703,314	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Electra Therapeutics, Inc.Listing unverified	Sep 23, 2026	Buy	1,000,000	15.00 USD	$15M	conv 78Unusual size	SEC
Electra Therapeutics, Inc.Listing unverified	Sep 23, 2026	Other	1,703,314	—	n/a (No price was disclosed in the filing)		SEC
Electra Therapeutics, Inc.Listing unverified	Sep 23, 2026	Other	2,002,310	—	n/a (No price was disclosed in the filing)		SEC
Electra Therapeutics, Inc.Listing unverified	Sep 23, 2026	Other	758,279	—	n/a (No price was disclosed in the filing)		SEC
Electra Therapeutics, Inc.Listing unverified	Sep 23, 2026	OtherD (derivative)	-1,087,934	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-513,067	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-10,690,530	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	513,067	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Buy	588,235	17.00 USD	$10M	conv 59Cluster	SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	769,601	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	1,333,975	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-564,187	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-7,127,019	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-2,000,962	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	564,187	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	10,690,530	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Buy	300,249	17.00 USD	$5.1M	conv 39Cluster	SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	7,127,019	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	2,000,962	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-1,333,975	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-256,448	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Buy	61,516	17.00 USD	$1M	conv 37Cluster	SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	Other	256,448	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 30, 2026	OtherD (derivative)	-769,601	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Electra Therapeutics, Inc.Listing unverified	Sep 23, 2026	OtherD (derivative)	-1,703,314	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Electra Therapeutics, Inc.Listing unverified	Sep 23, 2026	Buy	1,000,000	15.00 USD	$15M	conv 78Unusual size	SEC
Electra Therapeutics, Inc.Listing unverified	Sep 23, 2026	Other	1,703,314	—	n/a (No price was disclosed in the filing)		SEC
Electra Therapeutics, Inc.Listing unverified	Sep 23, 2026	Other	2,002,310	—	n/a (No price was disclosed in the filing)		SEC
Electra Therapeutics, Inc.Listing unverified	Sep 23, 2026	Other	758,279	—	n/a (No price was disclosed in the filing)		SEC
Electra Therapeutics, Inc.Listing unverified	Sep 23, 2026	OtherD (derivative)	-1,087,934	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC